so far investment in rimbayu has already contributed earning to Wcehb ?

actually without the one off gain on disposal of investment ( Rimbayu) , it would be in net losses of RM48m. correct me if i m wrong

because they need huge capital to execute their biz

agreed with wiseEye 's view. some of the companies although are high gearing but doesnt mean weak BS. It is depend on co's biz modal. some sectors biz modal used to hv high debt especially contruction , oil and gas companies

PSA. u already found and disclosed a lot of facts to real investors. They should realise and aware. no need to waste time to bother the promoters who pretend as investors in this forum. Thumb up to you !

Truly blessed to PSAi3invest and joyvest . Well done to alert the investors !!

Appreciate your effor and brave to disclose all the facts

@PSAi3alert. Good sharing !!! Make sense and logic findings . Experienced investors know what is happening to ucrest.

Thanks Kytan's sharing. Feel make sense of the facts given. As investors we need to share each other and analyse all the publicly available resources to connect all the dots. AsThere are many cases in market before where co released very positive business development news and cause their share price rocketing and later........ But cant deny there also many are real facts and news. This is the challenges in market which we need to encouter. All money are hard earned so be more cautious. Interesting is most of the pump and dump cos , their chart pattern almost the same. Hopefully we are the lucky ones.

just aware of that Ucrest only signed MOU with RDIF. MOU is non binding and legally no enforceable and is only an agreement to agree. Have experienced some cos published MOU and share price going up . but later nothing was materialised. need to monitor closely . Hope everything goes smooth then huat !!!

powerplay666, agree with ur view ( it's all about the relationship) South korea's houns global is a company specialized in the provision of pharmaceutical products. if it also playing the same role as ucrest ( as oem with higher production volume) looks fit to them as they should be more familiar to this industry. moreover it lead a consortium to produce the said vaccine by themself. Is that advisable to take this co share price movement ( listed in south korea) as guideline ??? Hopefully it share price keep on moving higher

powerplay666, if contract manufacturing facilities for ucrest also in india then very good. but logically think if they already has their local manufacturers. why still need contract manufacturer . Probably need ucrest imedic ?

from the articles related to spuntik v in india and south korea, seem like india n south korea already have their own manufacturers. very high chance ucrest is not involved in it. correct me if i m wrongly read.

India: Apart from partnership with Dr Reddy’s Labs that is conducting Sputnik V clinical trials locally, and have the distribution rights for the Russian vaccine, RDIF has entered manufacturing partnership with five other local companies for production https://www.hindustantimes.com/india-news/india-may-begin-sputnik-vaccine-import-by-may-start-production-around-july-101618461897427.html

a bit disappointed when noticed that south korea 's huons only up 16% on 16 apr after announced the news. is probably the manufacturer profit margin lower than the co that identify and manage contract manufacturer.

Russia has signed several major vaccine production deals with Indian manufacturers, and India is expected to become a hub for production of the shot. This is expected to begin in May.
https://www.reuters.com/business/healthcare-pharmaceuticals/india-receive-sputnik-v-vaccine-doses-this-month-tass-cites-ambassador-2021-04-15/

from the article , Huons estimated manufacturing of the said vaccin is quite huge which is ard 1.2b per year. Does ucrest also included in the supervising and managing south korea and india manufacturing ?

South Korean consortium to produce 100 million doses of Russia's Sputnik V vaccine per month . that means ard 1.2b per year . and noticed South Korea's Huons Global that it will lead a consortium to produce the spuntik vaccin share price up in the 16 morning ard 29.8% but close up 16% on 16 apr

@fengpinglangjing . i missed out the investor briefing , Sad !. just would like to confirm that The profit margin of rm1 - rm4 as oem managment was mentioned in the briefing ? if yes, really very good news and huat ar.

nice sharing. keep up your good work

RHB platform so far so today

fake news

Revenue n profit is dropping QOQ . Shares number keep on increasing ( diluting earning) . Bad sign ?

2.97

All also penny stocks and rocket high

One of the ages boss ,Liew is also the boss of arbb. This counter up a lot

MI is moving to 2.55

going to con ppl again

the shark would see if got any followers when pushing the prices, if no followers, they wouldnt continue to push up

yes, trive reach highest 0.27 on oct 2017

yes, more tower needed if 5G implemented

sharks r coming again

from day one before changing name to trive ( previously known as etitech) , its trading pattern , always the same, "PUMP AND DUMP". TOO BAD !

disappointed to its prices performance . hovering sideways more than a year

raw material ,rubber prices seem go down . might due to RM strengthening or coming QR lackluster

if not mistaken , 21st fox century theme park will be ready on mid-end2017